Search Results - "Singh, Mallika"
-
1
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
Published in Nature biotechnology (01-07-2012)“…Disappointing results from most late-stage clinical trials of cancer therapeutics indicate a need for improved and more-predictive animal tumor models. This…”
Get full text
Journal Article -
2
RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers
Published in Nature cell biology (01-09-2018)“…Oncogenic alterations in the RAS/RAF/MEK/ERK pathway drive the growth of a wide spectrum of cancers. While BRAF and MEK inhibitors are efficacious against BRAF…”
Get full text
Journal Article -
3
Systematic evaluation of common natural language processing techniques to codify clinical notes
Published in PloS one (07-03-2024)“…Proper codification of medical diagnoses and procedures is essential for optimized health care management, quality improvement, research, and reimbursement…”
Get full text
Journal Article -
4
Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
Published in Cancer research (Chicago, Ill.) (01-06-2012)“…The high failure rate of late-stage human clinical trials, particularly in oncology, predicates the need for improved translation of preclinical data from…”
Get full text
Journal Article -
5
Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
Published in Proceedings of the National Academy of Sciences - PNAS (19-02-2008)“…The secreted Bv8 protein has been recently characterized as a regulator of myeloid cell mobilization and a neutrophil-derived mediator of tumor angiogenesis in…”
Get full text
Journal Article -
6
Bi-steric mTORC1 inhibitors induce apoptotic cell death in tumor models with hyperactivated mTORC1
Published in The Journal of clinical investigation (01-11-2023)“…The PI3K/AKT/mTOR pathway is commonly dysregulated in cancer. Rapalogs exhibit modest clinical benefit, likely owing to their lack of effects on 4EBP1. We…”
Get full text
Journal Article -
7
Using Genetically Engineered Mouse Models of Cancer to Aid Drug Development: An Industry Perspective
Published in Clinical cancer research (15-09-2006)“…Recent developments in the generation and characterization of genetically engineered mouse models of human cancer have resulted in notable improvements in…”
Get full text
Journal Article -
8
Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer
Published in Nature communications (19-07-2024)“…Current KRAS G12C (OFF) inhibitors that target inactive GDP-bound KRAS G12C cause responses in less than half of patients and these responses are not durable…”
Get full text
Journal Article -
9
Barriers to point-of-care ultrasound utilization during cardiac arrest in the emergency department: a regional survey of emergency physicians
Published in The American journal of emergency medicine (01-03-2021)“…Though point-of-care ultrasound (POCUS) is recognized as a useful diagnostic and prognostic intervention during cardiac arrest (CA), critics advise caution…”
Get full text
Journal Article -
10
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growth
Published in Genes & development (15-05-2014)“…The spliceosome machinery is composed of multimeric protein complexes that generate a diverse repertoire of mRNA through coordinated splicing of heteronuclear…”
Get full text
Journal Article -
11
Effects of Anti-VEGF Treatment Duration on Tumor Growth, Tumor Regrowth, and Treatment Efficacy
Published in Clinical cancer research (01-08-2010)“…Inhibition of the vascular endothelial growth factor (VEGF) axis is the basis of all currently approved antiangiogenic therapies. In preclinical models,…”
Get full text
Journal Article -
12
Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
Published in Frontiers in immunology (29-09-2020)“…Shp1, encoded by the gene , is a protein tyrosine phosphatase that transduces inhibitory signals downstream of immunoreceptors in many immune cell types…”
Get full text
Journal Article -
13
Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
Published in Nature biotechnology (01-06-2010)“…Genetically engineered mouse models of cancer simulate the spontaneous development of tumors in their native tissue environment. Singh et al . establish their…”
Get full text
Journal Article -
14
Disparities in cannabis use and documentation in electronic health records among children and young adults
Published in NPJ digital medicine (08-08-2023)“…The legalizations of medical and recreational cannabis have generated a great deal of interest in studying the health impacts of cannabis products. Despite…”
Get full text
Journal Article -
15
Proapoptotic Activation of Death Receptor 5 on Tumor Endothelial Cells Disrupts the Vasculature and Reduces Tumor Growth
Published in Cancer cell (10-07-2012)“…The proapoptotic death receptor DR5 has been studied extensively in cancer cells, but its action in the tumor microenvironment is not well defined. Here, we…”
Get full text
Journal Article -
16
Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia
Published in Frontiers in oncology (02-08-2021)“…The mechanistic target of rapamycin (mTOR) is a kinase whose activity is elevated in hematological malignancies. mTOR-complex-1 (mTORC1) phosphorylates…”
Get full text
Journal Article -
17
Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer
Published in Molecular cancer therapeutics (01-01-2015)“…Activating mutations in the KRAS oncogene occur in approximately 90% of pancreatic cancers, resulting in aberrant activation of the MAPK and the PI3K pathways,…”
Get full text
Journal Article -
18
Mutator suppression and escape from replication error-induced extinction in yeast
Published in PLoS genetics (01-10-2011)“…Cells rely on a network of conserved pathways to govern DNA replication fidelity. Loss of polymerase proofreading or mismatch repair elevates spontaneous…”
Get full text
Journal Article -
19
Crystal Structure of BMP-9 and Functional Interactions with Pro-region and Receptors
Published in The Journal of biological chemistry (01-07-2005)“…Bone morphogenetic proteins (BMPs), a subset of the transforming growth factor (TGF)-β superfamily, regulate a diverse array of cellular functions during…”
Get full text
Journal Article -
20
Abstract IA-04: Targeting the oncogenic state of RAS with tri-complex inhibitors
Published in Cancer research (Chicago, Ill.) (15-09-2024)“…Abstract KRAS oncogenic driver mutations occur in approximately 30% of all human cancers, and in particular, in over 90% of patients with pancreatic ductal…”
Get full text
Journal Article